JSPR
Closed
Jasper Therapeutics Inc
5.74
+0.19 (+3.42%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 5.55
Day's Range: 5.4972 - 6.1
Send
sign up or login to leave a comment!
When Written:
1.47
Jasper Therapeutics Inc is a biotechnology company that focuses on developing curative therapies based on the science of stem cells. The company was founded in 2019 and is headquartered in Palo Alto, California.
Jasper Therapeutics is developing a platform technology called JSP191, which is a humanized monoclonal antibody that targets and depletes hematopoietic stem cells (HSCs) in the bone marrow. The company is using JSP191 in combination with bone marrow transplant to treat patients with a variety of blood disorders, including severe sickle cell disease and beta-thalassemia.
The company has also developed a proprietary technology called JSP001, which is a non-viral gene editing platform that can be used to modify HSCs outside the body, allowing for targeted genetic modifications to be made to the cells before they are infused back into the patient.
Jasper Therapeutics has received funding from a number of sources, including venture capital firms and government grants. The company is led by a team of experienced biotechnology executives and scientists.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Jasper Therapeutics is developing a platform technology called JSP191, which is a humanized monoclonal antibody that targets and depletes hematopoietic stem cells (HSCs) in the bone marrow. The company is using JSP191 in combination with bone marrow transplant to treat patients with a variety of blood disorders, including severe sickle cell disease and beta-thalassemia.
The company has also developed a proprietary technology called JSP001, which is a non-viral gene editing platform that can be used to modify HSCs outside the body, allowing for targeted genetic modifications to be made to the cells before they are infused back into the patient.
Jasper Therapeutics has received funding from a number of sources, including venture capital firms and government grants. The company is led by a team of experienced biotechnology executives and scientists.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!